EDTUTC-4 New YorkLog in Sign up

PALI
Palisade Bio, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:59 PM EDT

1.45USD+1.399%(+0.02)1,996,077

Pre-marketOct 5, 2026 8:58:30 AM EDT

1.4498USD+0.681%(+0.0098)

After-hoursOct 2, 2026 4:41:30 PM EDT

1.43USD-1.379%(-0.02)

PALI News

Day breaks

08:50 AM EDTPalisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026 ·

GlobeNewswire Inc.

01:36 PM EDTPalisade Bio at Stifel forum: pde4 bet advances into phase 2 ·

Investing.com

08:45 AM EDTPalisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance ·

GlobeNewswire Inc.

08:35 AM EDTPalisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD ·

GlobeNewswire Inc.

09:00 AM EDTPalisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum ·

GlobeNewswire Inc.

02:30 AM EDTMarket Movers | Winners: BBNX, EMAT, BRUN | Losers: PALI, ALHC, JBHT ·

Trefis

06:01 PM EDTPalisade Bio, Inc. (PALI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

03:34 PM EDTPalisade Bio at H.C. Wainwright conference: IBD drug push ·

Investing.com

10:25 AM EDTPalisade Bio at Morgan Stanley conference: broadens ibd push ·

Investing.com

09:00 AM EDTPalisade Bio to Participate in Upcoming Investor Conferences ·

GlobeNewswire Inc.